Pralsetinib in patients with RET fusion –positive non-small cell lung cancer: A plain language summary of the ARROW study

Future Oncology, Ahead of Print.

Source: Future Oncology - November 2, 2023 Category: Cancer & Oncology Authors: Frank Griesinger Giuseppe Curigliano Vivek Subbiah Christina S Baik Daniel SW Tan Dae H Lee Daniel Misch Elena Garralda Dong-Wan Kim Anthonie J van der Wekken Justin F Gainor Luis Paz-Ares Stephen V Liu Gregory P Kalemkerian Daniel W Bowles Aaron S Mansfi Source Type: research